History
Endorsement Maintenance
Endorsed
Jan 18, 2012
Release Note: The measure and specifications have been updated to align with the 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease which now recommends the use of beta-blocker therapy for 3 years following MI or ACS as opposed to indefinite use as previously recommended. Additional limited changes have been incorporated to adhere to current eCQM industry standards while preserving the original measure intent.
Disclaimer: This information is for personal and noncommercial
use only. You may not modify, reformat, copy, display, distribute, transmit, publish,
license, create derivative works from, transfer or sell any information, products
or services obtained from this document.